Canada’s Cannabis Market Grew 6.5% as Alcohol Shrank. The Substitution Trade Is Real — and It’s Coming for U.S. Markets.

Ottawa doesn’t usually move cannabis stocks. But the data Statistics Canada published this month should be required reading for anyone who wants to understand where this industry is heading — and why Big Alcohol is suddenly very interested in capturing the hemp-derived THC drink market.

For the fiscal year ending March 31, 2025, Canadians spent $5.5 billion on cannabis products. Sales grew 6.5 percent year-over-year. Over the same period, alcohol revenue declined 1.6 percent. In isolation, neither number is dramatic. Compounded across seven years of national legalization, the trend line is unambiguous: cannabis is taking spending from alcohol, and it isn’t giving it back.

What the Data Actually Says

The Statistics Canada report doesn’t use the phrase “substitution effect.” It doesn’t need to. The agency tracks retail sales across both categories at the national level — the same methodology, the same fiscal year, the same consumer base. The divergence isn’t a modeling artifact. It’s what Canadians are actually buying less of and more of.

Herbal cannabis products still dominate the mix, accounting for roughly 60 percent of total sales. The remaining 40 percent — oils, edibles, capsules, concentrates, and beverages — is where the category is evolving fastest. Cannabis beverages in particular have steadily grown their share of the Canadian market since legalization, giving U.S. observers a clear preview of where the domestic THC drink sector is likely to go.

Canada legalized adult-use cannabis nationally in October 2018. What the 2025 fiscal data captures is a market that has had nearly eight full years to normalize — to become the default, not the novelty. That distinction matters for interpreting the numbers. This isn’t the early-adopter enthusiasm that inflated first-year Canadian sales. This is what a mature legal cannabis market looks like when consumers have fully adjusted their behavior.

The Research Behind the Trade-Off

The substitution argument has been circulating in cannabis policy circles for years, backed by a growing body of peer-reviewed evidence. Survey data published in The Harm Reduction Journal in 2024 found that 60 percent of cannabis consumers report using it specifically to reduce alcohol intake. Research from California — cited by NORML — identified a measurable relationship between legal cannabis access and declining alcohol consumption at the state level.

Canada’s Statistics Canada data is the largest-scale confirmation yet that these patterns hold at the level of an entire national market, over multiple business cycles, through a pandemic and its recovery. The alcohol industry has spent years arguing that cannabis substitution is overstated or anecdotal. The Canadian government’s own statistical agency now says otherwise.

For U.S. cannabis investors, this is not merely a Canadian story. It’s a data series that validates one of the sector’s most important long-term revenue theses: that legal cannabis is not just a new category competing for shelf space, but a structural disruptor of one of the most established consumer spending categories in the world.

Big Alcohol Is Paying Attention — and Acting on It

The major alcohol companies have read the same data. This week, reporting from High Times revealed that large alcohol industry players are actively lobbying federal regulators to bring varies by state them, but to own the distribution channel. The proposal: regulate hemp THC drinks like beer, routed through the existing three-tier system and sold alongside alcohol in licensed retail, rather than through cannabis dispensaries.

The framing is consumer protection. The logic is competitive defense.

If the Canadian substitution data is predictive — and there is no structural reason why it shouldn’t be, given that U.S. consumer behavior around alcohol has tracked similar patterns in legal states — alcohol companies are looking at the same trend line and drawing the obvious conclusion: the cannabis beverage category is going to take meaningful share from beer and spirits over the next decade. The question for them is whether they’re inside the tent or outside it when that happens.

The catch for cannabis operators is significant. Folding hemp THC drinks into alcohol-controlled distribution would effectively strand the independent brands, MSO-affiliated beverage lines, and craft producers who have spent years building the category through dispensary channels. It would also hand the customer relationship — and the shelf — to an industry that has every incentive to position cannabis beverages as supplements to alcohol spending rather than substitutes for it. That’s the catch. Big Alcohol wants to save the category on terms that serve Big Alcohol.

What U.S. Operators Should Watch

The Canadian data adds specific weight to a few investment theses that have been harder to prove in U.S. markets, where state-by-state legalization has made macro-level substitution data harder to isolate.

Volume, not premium, is the growth driver. Canada’s cannabis market grew despite continued price compression in dried flower — the same dynamic compressing margins in U.S. markets. The lesson is that access and normalization drive volume more effectively than premium positioning does. MSOs banking on luxury-tier margins should note that the Canadian market’s growth came from category expansion, not price escalation.

The beverage category is not a sideshow. The 40 percent of Canadian sales that sits outside herbal products is where the real consumption evolution is happening. Cannabis beverages — low-dose, sessionable, alcohol-adjacent in occasion — are the product format most directly positioned to capture incremental alcohol spending. U.S. operators who have built beverage infrastructure are sitting on the right side of that trade.

The tax structure will eventually have to change. Several U.S. states built cannabis excise tax frameworks on the assumption that the market would be additive — new revenue without disrupting existing alcohol tax flows. If the Canadian trend holds, that assumption has a shelf life. States will face pressure to revisit both cannabis tax rates and alcohol tax policy as spending shifts between categories.

Timeline matters. Canada’s substitution data reflects a market that has had eight years to mature. States that legalized in 2019 or 2020 may only now be entering the behavioral normalization phase where substitution effects become measurable. The U.S. data won’t look like Canada’s until the market is old enough to generate the same kind of longitudinal signal. But the destination is becoming clearer.

The $5.5 billion isn’t just a Canadian headline. It’s a preview of where U.S. cannabis market dynamics are heading — and a warning shot to every alcohol company that hasn’t yet figured out what to do about it.

Sources: Statistics Canada, fiscal year ending March 31, 2025; NORML; The Harm Reduction Journal (2024); High Times, March 25, 2026.